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Carcinoma of the cervix is causally related to infection with the human papillomavirus (HPV), and T cells
play a pivotal role in the immune response of the host to rid itself of HPV infection. Therefore, we assessed the
T-cell function of women with HPV-related cervical neoplasia against a superantigen, Staphylococcus entero-
toxin B (SEB). Each woman provided a cervical brush specimen for HPV DNA testing and Papanicolaou (Pap)
smears for the staging of cervical lesions. They also provided a blood specimen for determination of the ability
of CD4 T and CD8 T cells to synthesize Th1 (interleukin-2 [IL-2], gamma interferon [IFN-], and tumor
necrosis factor alpha [TNF-]) and Th2 (IL-10) cytokines in response to activation with SEB. Compared with
control subjects with self-attested negative Pap smears, women with high-grade squamous intraepithelial
lesions (HSIL) had significantly lower percentages of activated CD4 T cells that produced IL-2 (P  0.045),
IFN- (P  0.040), and TNF- (P  0.015) and a significantly lower percentage of activated CD8 T cells that
produced IL-2 (P < 0.01). These data indicate that women with HPV-related cervical HSIL show a decrease in
Th1 cytokine production by activated CD4 T cells and suggested that compromised T-helper functions may
negatively impact the function of cytotoxic CD8 T cells.
Infection with oncogenic human papillomavirus (HPV) can
cause precancerous lesions of the cervical squamous epithe-
lium (6). Clinical manifestation with HPV infection is depen-
dent upon epithelial location, HPV type, and host immune
responses (12). With respect to the host immune status, indi-
viduals with compromised cellular immunity are more likely to
develop cervical lesions than those with intact cellular immu-
nity (10). Moreover, a shift from a Th1 (interleukin [IL-2] and
gamma interferon [IFN-]) to a Th2 (IL-4 and IL-10) cytokine
profile was associated with poor prognosis for patients with
HPV-associated cervical lesions (4). IL-10 in particular blocks
cytokine synthesis by helper T cells, activated monocytes, and
natural killer (NK) cells (20). A decrease in NK cell activity has
been associated with reactivation of latent HPV infection (7).
HPV may escape host immune surveillance by depleting intra-
epithelial antigen-presenting cells (21) and/or by downregulat-
ing the surface expression of major histocompatibility complex
class I antigens and 2-microglobulin on antigen-presenting
cells (24).
Investigators who conducted an earlier study reported that
phytohemagglutinin-activated peripheral blood mononuclear
cells of patients with local and invasive cervical lesions pro-
duced less IL-2 and IFN- than similar cell cultures of control
subjects (4). In a later study (13), Lee et al. used a mechanism
that bypassed the T-cell receptor (TCR) (25) to examine cy-
tokine production by T cells that were activated by phorbol-
12-myristate-13-acetate, an activator of protein kinase C. In
that study, Lee et al. expanded on the observations of Clerici
and coworkers (4) by demonstrating a deficiency in cytokine
synthesis by CD4 T and CD8 T cells of HPV-infected
women. As activation of T cells by HPV antigens is mediated
through a mechanism that engages the TCR, the present study
investigated the ability of CD4 T and CD8 T cells of HPV-
infected women with cervical squamous intraepithelial lesions
(SIL) to synthesize Th1 and Th2 cytokines following activation
with Staphylococcus enterotoxin B (SEB), a microbial superan-
tigen that activates T cells through the TCR (22).
MATERIALS AND METHODS
Subjects. A total of 98 women (referred to the colposcopy clinic at one of three
hospitals [Memorial-Hermann Hospital, Lyndon Baines Johnson Hospital, or
the University of Texas M.D. Anderson Cancer Center] in Houston, Texas) were
recruited over a 12-month period for this laboratory study. The Institutional
Review Board at each of the individual study sites approved the study. Patients
consented to provide a cervical smear for cytologic examination by Papanicolaou
(Pap) staining, cervical brush specimens for HPV testing, and answers to a
questionnaire of risk factors. Women also agreed to undergo a cervical biopsy if
lesions were visible upon application of acetic acid. Histologically confirmed
cases of cervical intraepithelial neoplasia (CIN) grades 2 to 3 were treated by a
loop electrosurgical excision procedure. In addition to receiving treatment, each
patient agreed to provide 5 ml of peripheral blood for investigational cytokine
studies at the time of administering the questionnaire and prior to a physical
examination and gynecologic procedure. Healthy control subjects were recruited
for this study through a widely circulated flyer seeking nonsmoker female blood
donors. Each control subject attested to having a negative Pap smear at her
annual well-women gynecological examination. Questionnaires of risk factors
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were not administered to control subjects, and no control subject was asked to
provide cervical specimens for cytologic examination and HPV testing at the time
of phlebotomy.
Processing and interpretation of enrollment specimens.
Cytology studies. Pap smears were screened by a cytotechnologist and evalu-
ated by a cytopathologist, Anais Malpica. The Bethesda System was used to
classify the cytologic findings for each woman into one of three stages of increas-
ing disease severity: atypical squamous cells of unknown origin (ASCUS), low-
grade SIL (LSIL), and high-grade SIL (HSIL) (17). In cases in which operable
lesions were present, patients were referred to a colposcopy clinic for cervical
biopsy and histological examination. Finally, a clinical diagnosis was rendered on
the basis of the cytology, histology, and HPV test results.
Detection of HPV DNA in cervical specimens. Exfoliated epithelial cells from
all patients were obtained by cervical brushing and placed in transport medium
supplied with a specimen collection kit of a Hybrid Capture 2 (HC2) assay
(Digene Diagnostics, Gaithersburg, Md.) for the detection of HPV DNA. The
HC2 assay is a nucleic acid hybridization assay that uses RNA probes to detect
18 HPV types, including 13 high-risk types (types 16, 18, 31, 33, 35, 39, 45, 51, 52,
56, 58, 59, and 68) and 5 low-risk types (types 6, 11, 42, 43, and 44). In some cases,
a second cervical specimen was also collected to test for HPV DNA through the
use of a previously described PCR method that amplified a highly conserved
segment (450 bp) of the L1 gene with primers MY09 and MY11 (2, 9).
Intracellular cytokine synthesis by T-cell subsets activated by SEB. Each study
and control subject provided 5 ml of peripheral blood in heparin for an intra-
cellular cytokine assay that assessed the ability of T cells to synthesize cytokines
following activation with SEB. Briefly, 1 ml of peripheral blood was grown in a
culture in the presence of 3 g of SEB, 3 g of anti-CD28, and 3 g of
anti-CD49d and incubated at 37°C for 5 h. At 2 h into the incubation period, 10
g of brefeldin A, a nontoxic but potent inhibitor of intracellular transport, was
added for the remaining 3 h of the incubation period. Anti-CD28 and anti-
CD49d were purchased from Becton Dickinson Immunocytometry Systems
(Mountain View, Calif.); other reagents were purchased from the Sigma Chem-
ical Company (St. Louis, Mo.).
The SEB-activated cells were stained for cytokines in the cytoplasm, and the
stained cells were analyzed using four-color flow cytometry and a modification of
the previously described procedure of Lee et al. (14). Briefly, 10,000 CD3 gated
events were collected on the basis of the side scatter of lymphocytes and their
reactivity with anti-CD3 monoclonal antibody. Anchoring on CD3 events, a
scatter plot was created on the basis of reactivity with anti-CD8 monoclonal
antibody to delineate two populations of interest: CD3 CD8 clusters and
CD3 CD8 (or CD4) clusters. Next, using the CD3 CD8 and CD3 CD4
clusters of T cells as anchors, two scatter plots were constructed to identify the
SEB-activated T cells that coexpressed CD69 and one of the following cytokines:
IL-2, IFN-, tumor necrosis factor alpha (TNF-), or IL-10. Immunoglobulin
isotype controls were used to verify the staining specificity of the anti-cytokine
reagents and to set markers delineating positive- and negative-testing popula-
tions.
Statistical analysis. Pearson’s chi-square analysis was used to determine dif-
ferences in the ethnic distribution, the number of women with cervicovaginal
infections, and the proportion of smokers and oral contraceptive pill (OCP)
users among patient populations. The Mann-Whitney test was performed to
determine age differences between study groups. The median percentages of
T-cell subsets synthesizing IL-2, IFN-, TNF-, or IL-10 were obtained for
patients and control subjects. The Kruskal-Wallis and Mann-Whitney tests were
employed to determine the statistical differences among and between the study
groups, respectively. Statistical differences with a P value of less than 0.05 were
considered to be significant.
RESULTS
Patient demographics, HPV status, and clinical staging.
Only patients with HPV detectable by the HC2 assay were
grouped according to pathological findings regarding their le-
sions. Cervical brushings from some patients were also positive
by the PCR for HPV-DNA. A single pathologist reviewed all
cervical biopsy specimens to provide consistent histological
staging with respect to either LSIL or HSIL. In our study,
women with biopsy-proven CIN were excluded from the
ASCUS group for data analysis. The analysis included 64
HPV patients: 14 women with ASCUS, 21 women with LSIL,
and 29 women with HSIL.
The 64 study subjects had a median age of 30 years (range,
20 to 63 years of age) (Table 1) and were age matched to 15
control female nonsmokers with a median age of 33 (range, 23
to 61 years). The patient population consisted of 16 African-
American, 24 Hispanic, 22 Caucasian, and 2 Asian women.
Among the patient groups, there were no significant differ-
ences in ethnicity (2  7.313 [P  0.293]), proportions of
smokers (2  2.787 [P  0.248]) and OCP users (2  1.733
[P  0.420]), and the number of women with past cervicovagi-
nal bacterial or yeast infections and sexually transmitted dis-
eases (2  2.046 [P 0.359]) (Table 1). Parity among patients
increased with HPV disease severity such that the average
number of children per patient group was 1 for ASCUS
women, 2 for LSIL women, and 3 for HSIL women, respec-
tively. All women self attested to having no human immuno-
deficiency virus infection. Concomitant cervicovaginal infec-
tions in patients were rare at the time of study; one woman
with LSIL had a yeast infection and another woman with HSIL
had a chlamydia infection.
Syntheses of Th1 and Th2 cytokines by SEB-activated T
cells. (i) Cytokine synthesis by CD4 T cells. The median
percentages of CD4 and IL-2 T cells were 8.0% (95% con-
fidence intervals, 5.6 and 10.6%, respectively) for ASCUS,
6.7% (5.4 and 9.8%) for LSIL, 4.2% (4.1 and 6.6%) for HSIL,
and 7.0% (5.9 and 12.4%) for control subjects (Fig. 1a). The
median percentages of CD4 and IFN- T cells were 6.2%
(95% confidence intervals, 4.0 and 9.4%, respectively) for
ASCUS, 5.7% (4.1 and 7.3%) for LSIL, 4.4% (3.8 and 5.8%)
for HSIL, and 7.6% (5.3 and 10.3%) for control subjects (Fig.
1b). The median percentages of CD4 and TNF- T cells
were 16.0% (95% confidence intervals, 9.9 and 17.2%, respec-
tively) for ASCUS, 12.6% (9.2 and 14.4%) for LSIL, 8.2% (7.9
and 11.6%) for HSIL, and 18.3% (12.3 and 21.4%) for control
subjects (Fig. 1c). In particular, patients with HSIL had signif-
icantly lower median percentages of CD4 T cells that pro-
duced IL-2 (P  0.045), IFN- (P  0.040), and TNF- (P 
0.015) than the control subjects, who had responses similar to
those of patients with ASCUS and LSIL. The percentages of
TABLE 1. Ethnicity, smoking status, OCP usage, and past
cervicovaginal infections in each of the patient populations
Parameter
Value for groupa
ASCUS LSIL HSIL
Total subjects 14 21 29
Ethnicity was:
African-American 2 5 9
Hispanic 3 10 11
Caucasian 8 5 9
Asian 1 1 0
Mean age (min, max)b 31 (21, 56) 29 (20, 45) 31 (20, 63)
Smokers 4 7 15
OCP users 2 3 8
Past infectionc 10 12 22
a Except where noted, values are numbers of women.
b Ages are in years. Min, minimum; max, maximum.
c Past cervicovaginal bacterial or yeast infections and/or sexually transmitted
diseases were considered.
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FIG. 1. Box-and-whisker plots of the percentages of type 1 cytokine-producing CD4 T cells for each of four study groups (14 women with
ASCUS, 21 women with LSIL, 29 women with HSIL, and 15 control subjects). The box extends from the 25th percentile to the 75th percentile, with a
horizontal line at the median (50th percentile). Whiskers extend down to the smallest value and up to the largest (range), excluding the outliers. Figures
1a, 1b, and 1c represent the plots of activated CD4 T cells that expressed IL-2, IFN-, and TNF-, respectively. Asterisks indicate that patients with
HSIL had significantly lower median percentages of activated CD4 T cells that expressed either IL-2 (P  0.045), IFN- (P  0.040), or TNF- (P 
0.015) compared to the results seen with activated CD4 T cells of control subjects, as determined by the Mann-Whitney test.
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CD4 T cells expressing IL-10 were similar for all groups (data
not shown).
(ii) Cytokine synthesis by CD8 T cells. The median per-
centages of CD8 and IL-2 T cells were 1.0% (95% confi-
dence intervals, 0.7 and 1.9%, respectively) for ASCUS, 1.5%
(1.0 and 2.7%) for LSIL, 1.0% (0.8 and 1.5%) for HSIL, and
3.3% (2.5 and 5.7%) for control subjects (Fig. 2a). The median
percentages of CD8 and IFN- T cells were 7.1% (95%
confidence intervals, 5.1 and 9.7%, respectively) for ASCUS,
6.3% (4.7 and 8.3%) for LSIL, 5.0% (4.7 and 7.9%) for HSIL,
and 6.9% (5.0 and 11.0%) for control subjects (Fig. 2b). The
median percentages of CD8 and TNF- T cells were 5.9%
(95% confidence intervals, 4.8 and 8.4%, respectively) for
ASCUS, 7.2% (5.1 and 8.9%) for LSIL, 4.9% (4.3 and 7.2%)
for HSIL, and 11.4% (5.7 and 13.7%) for control subjects (Fig.
2c). The percentages of CD8 T cells that produced IL-2
differed significantly among study groups (P  0.003). Patients
with ASCUS (P  0.003), LSIL (P  0.007), and HSIL (P 
0.001) had significantly lower median percentages of CD8 T
cells that produced IL-2 than the control subjects. All groups
had similar median percentages of CD8 T cells that produced
either IFN- or TNF-. The percentages of CD8 T cells that
produced IL-10 were similar for all groups (data not shown).
DISCUSSION
Cytokine production by T cells is a reliable measure of the
quality of cell-mediated immunity. In an earlier study, Lee et
al. found that a significantly lower percentage of CD4 T cells
of patients with HPV-related cervical neoplasia synthesized
IL-2 in response to activation with phorbol-12-myristate-13-
acetate, an activator of protein kinase C that activates T cells
through a mechanism that is independent of TCR-mediated
signaling, compared with the results seen with CD4 T cells of
control subjects (14). In the present study we showed that the
activation of T cells by a superantigen, SEB, through the TCR
is compromised in patients with HSIL. In particular, patients
with HSIL had significantly lower percentages of CD4 T cells
that produced Th1 cytokines (IL-2, IFN-, and TNF-) than
control subjects. Our data further demonstrated that impair-
ment of IL-2 production by CD8 T cells was detected not only
in patients with HSIL but also in women who had LSIL or
ASCUS. In contrast, all patient groups had similar percentages
of CD8 T cells that produced IFN-. These data are consis-
tent with the results of a recent report from studies of mice; the
results showed that low-avidity TCR ligand was able to drive
IFN- production whereas IL-2 production required a strong
TCR engagement (1). This impaired IL-2, and not IFN-,
production by CD8 T cells of all patient groups suggested a
functional heterogeneity among CD8 T cells in women at
precancerous stages of HPV disease.
SEB is a microbial antigen that induces vigorous activation,
proliferation, and cytokine production by T cells that express
specific TCR variable beta (V) chains such as V3, V12,
V14, V15, V17, and V20 (22). In vivo administration of
SEB resulted in clonal expansion and subsequent deletion of
TCR V-specific responding T cells; moreover, in vitro stim-
ulation of CD4 and CD8 T cells with SEB caused anergy
only in CD4 T cells and not in CD8 T cells (11). Whereas
chronic and persistent antigenic stimulation may lead to the
deletion of specific V clones in patients with cervical cancer
(19), defects in cytokine production by T cells may not be
exclusively due to persistent stimulation by HPV antigen. As it
is common for women with CIN to have concurrent bacterial
and yeast infections (23), chronic antigen stimulation by mi-
crobial antigens could potentially eliminate certain TCR V
clones and, in turn, compromise the ability of T cells to re-
spond to SEB. HPV infection usually precedes detection of
bacterial vaginosis among young women (15), and cumulative
insults to the host immune system by chronic and repetitive
infections can lead to the development of CIN (8). While the
patients of the present study had a low incidence of concurrent
cervicovaginal infections, prior incidences of sexually transmit-
ted diseases are a measure of risk behavior that increases
exposure to HPV infection, which in turn increases the risk of
developing CIN. As this was a cross-sectional study that sur-
veyed for a limited number of cervicovaginal infections without
the assessment of the TCR V repertoire, it is difficult to
determine the true impact of prior cervicovaginal infections on
the T-cell repertoire and the ability of T cells to respond to
antigenic stimulation.
An earlier study demonstrated that cultures of peripheral
blood mononuclear cells from patients with local and invasive
cervical lesions that were activated with phytohemagglutinin
produced lower levels of IFN- than similar cultures of control
subjects (4). By assessing intracellular cytokine synthesis by
SEB-activated T cells, we found significantly lower percentages
of CD4 T cells (but not CD8 T cells) that produced IFN-
among patients with HSIL compared with the results seen with
T-cell subsets of the control subjects. Others have reported
that compared with the memory CD4 T cell, the memory
CD8 T cell is more conducive to activation with SEB and
more likely to secrete cytokine and proliferate (5). With re-
spect to HPV-infected women, cervical CD8 T cells produced
IFN- in response to activation with HPV-L1 antigen (18).
These data (in combination with findings with respect to the
ability of SEB-activated CD8 T cells of women with cervical
SIL to produce TNF-) suggest that the cytolytic capacity of
CD8 T cells might not be compromised (3). Nevertheless, the
deficiency in IL-2 production by CD4 T and CD8 T cells of
patients with HSIL may limit the expansion of HPV-specific
cytotoxic T-cell clones and in turn impair the ability of patients
to sustain competent cell-mediated responses.
The lack of data on the presence of HPV DNA and risk
factors among control subjects is one of the limitations of this
study. On the other hand, the lack of statistically significant
differences in risk behaviors such as smoking, OCP use, and
past history of cervicovaginal infections and sexually transmit-
ted diseases among our patient populations suggests that the
impact of these risk factors in this study was minimal. Perhaps
the sample size of our study was not sufficiently large to de-
termine epidemiological differences among cohorts. Other
variables, such as the number of cigarettes smoked, the num-
ber of sex partners, the incidence and type of sexually trans-
mitted disease, and psychosocial factors, could potentially in-
fluence the course of disease evolution (16). The results of the
present study indicated the existence of a potential defect in
CD4 T-cell function that could in turn compromise the HPV-
specific cellular response of HSIL patients. A prospective lon-
gitudinal study to evaluate cellular immunity and the progres-
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FIG. 2. Box-and-whisker plots of the percentages of type 1 cytokine-producing CD8 T cells for each of four study groups (14 women with
ASCUS, 21 women with LSIL, 29 women with HSIL, and 15 control subjects). The box extends from the 25th percentile to the 75th percentile,
with a horizontal line at the median (50th percentile). Whiskers extend down to the smallest value and up to the largest (range), excluding the
outliers. Figures 2a, 2b, and 2c represent the plots of activated CD8 T cells that expressed IL-2, IFN-, and TNF-, respectively. Double asterisks
indicate that patients with either ASCUS, LSIL, or HSIL had significantly lower median percentages of activated CD8 T cells that expressed IL-2
(P 	 0.01) compared to the results seen with activated CD8 T cells of control subjects, as determined by the Mann-Whitney test.
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sion of cervical lesions in women with HPV infection may
provide a better understanding of the immune defects involved
in the development of invasive cervical neoplasia.
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